Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer

by Darcie D. Seachrist, Steven T. Sizemore, Emhonta Johnson, Fadi W. Abdul-Karim, Kristen L. Weber Bonk, Ruth A. Keri
Published 2017-06-01

ITGA2 promotes expression of ACLY and CCND1 in enhancing breast cancer stemness and metastasis

by Valery Adorno-Cruz, Andrew D. Hoffmann, Xia Liu, Nurmaa K. Dashzeveg, Rokana Taftaf, Brian Wray, Ruth A. Keri, Huiping Liu
Published 2021-07-01

Krüppel-like Factor 4 Inhibits Tumorigenic Progression and Metastasis in a Mouse Model of Breast Cancer

by Jennifer L Yori, Darcie D Seachrist, Emhonta Johnson, Kristen L Lozada, Fadi W Abdul-Karim, Lewis A Chodosh, William P Schiemann, Ruth A Keri
Published 2011-07-01

KLF4 defines the efficacy of the epidermal growth factor receptor inhibitor, erlotinib, in triple-negative breast cancer cells by repressing the EGFR gene

by Melyssa S. Roberts, Lindsey J. Anstine, Viviane S. Finke, Benjamin L. Bryson, Bryan M. Webb, Kristen L. Weber-Bonk, Darcie D. Seachrist, Parth R. Majmudar, Ruth A. Keri
Published 2020-06-01

Hotspots of aberrant enhancer activity punctuate the colorectal cancer epigenome

by Andrea J. Cohen, Alina Saiakhova, Olivia Corradin, Jennifer M. Luppino, Katreya Lovrenert, Cynthia F. Bartels, James J. Morrow, Stephen C. Mack, Gursimran Dhillon, Lydia Beard, Lois Myeroff, Matthew F. Kalady, Joseph Willis, James E. Bradner, Ruth A. Keri, Nathan A. Berger, Shondra M. Pruett-Miller, Sanford D. Markowitz, Peter C. Scacheri
Published 2017-02-01